Biologic data protections among issues in U.S.-EU trade talks

07/7/2013 | Bloomberg Businessweek

A round of negotiations beginning today between the European Union and the U.S. could lead to a trade pact that would affect wide-ranging regulations and patent protections on issues that include pharmaceuticals, highway safety and copyrighted music. Drugmakers want the 12-year protection for biologic drug data that they have in the U.S.

View Full Article in:

Bloomberg Businessweek